Medicare

Commentary

The illogical California lockdown orders

Get ready to stay home indefinitely, my fellow Californians. Gov. Gavin Newsom has suggested that the stay-at-home order he issued Dec. 3 will likely be extended well into January. So for a few more weeks — at least — most Californians won’t be able to engage in a wide range ...
Commentary

Why Joe Biden must keep Donald Trump’s short-term health plans in place

President-elect Joe Biden has promised “a dramatic expansion of health care coverage and bold steps to lower health care costs” once he takes office after his inauguration Jan. 20. But one of his first orders of business may undermine both those goals in one fell swoop. The incoming administration has signaled its intention to roll ...
Commentary

Americans are getting a good return on their healthcare spending

The Centers for Medicare and Medicaid Services released new data on Dec. 16 on health expenditures. In 2019, overall spending rose 4.6% to reach a total of $3.8 trillion, or 17.7% of the economy. That’s enough to make anyone do a double take. But a deeper look at the data ...
Commentary

COVID vaccines can give economy a needed shot in the arm once essential workers vaccinated

The arrival of two coronavirus vaccines authorized by the Food and Drug Administration for emergency use this month has prompted fierce debate about who ought to be immunized first. The latest guidelines from the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices put health care workers and older Americans living in nursing ...
Commentary

COVID-19 has shown us how dysfunctional the American regulatory state can be

In November, the Food and Drug Administration approved the first rapid at-home coronavirus test. That would seem to be unabashedly good news. But it’s actually an indictment of federal regulators, who have moved at a snail’s pace in the fight against the coronavirus. These delays have been concerning for folks ...
Commentary

Reforming Rebate Contracting will Improve Drug Affordability

By Wayne Winegarden and Robert Popovian The Department of Health and Human Services (HHS) finalized a regulation on November 20, 2020 that removed the safe harbor protections for rebates on prescription drugs paid to pharmacy benefit managers (PBMs) and Part D plans. This analysis evaluates the expected impact from this ...
Commentary

Work Requirements Can Preserve Medicaid For Those Who Need It Most

This month, the U.S. Supreme Court agreed to hear a case early next year that will decide whether states have the power to impose work requirements as a condition of receiving Medicaid benefits. The question before the high court is a legal one. But as a matter of policy, work requirements are a great ...
Commentary

The coming vaccine doesn’t mean we should delay routine care

This week, the first round of people began receiving a vaccine against COVID-19 in the United States. That offers some hope that we’ll finally be able to get the pandemic under control. Some people may take the arrival of a vaccine to mean that they can wait a few more months for ...
Commentary

Moderna COVID vaccine gets key endorsement — vaccinations are safe and will end pandemic

The vote Thursday by a U.S. Food and Drug Administration advisory panel to recommend an emergency use authorization for Moderna’s coronavirus vaccine is an important and welcome step in our battle to end the COVID-19 pandemic. Vaccinations are now underway with the Pfizer-BioNTech vaccine. People will begin received inoculations of the ...
Drug Pricing

NEW BRIEF: Tearing Down Drug ‘Rebate Walls’ Would Save Patients, Improve Health Care Outcomes

Tearing down drug “rebate walls” that increase patient costs and block access to cheaper and often more effective medications would increase competition, lower out-of-pocket costs, and improve health outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click ...
Commentary

The illogical California lockdown orders

Get ready to stay home indefinitely, my fellow Californians. Gov. Gavin Newsom has suggested that the stay-at-home order he issued Dec. 3 will likely be extended well into January. So for a few more weeks — at least — most Californians won’t be able to engage in a wide range ...
Commentary

Why Joe Biden must keep Donald Trump’s short-term health plans in place

President-elect Joe Biden has promised “a dramatic expansion of health care coverage and bold steps to lower health care costs” once he takes office after his inauguration Jan. 20. But one of his first orders of business may undermine both those goals in one fell swoop. The incoming administration has signaled its intention to roll ...
Commentary

Americans are getting a good return on their healthcare spending

The Centers for Medicare and Medicaid Services released new data on Dec. 16 on health expenditures. In 2019, overall spending rose 4.6% to reach a total of $3.8 trillion, or 17.7% of the economy. That’s enough to make anyone do a double take. But a deeper look at the data ...
Commentary

COVID vaccines can give economy a needed shot in the arm once essential workers vaccinated

The arrival of two coronavirus vaccines authorized by the Food and Drug Administration for emergency use this month has prompted fierce debate about who ought to be immunized first. The latest guidelines from the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices put health care workers and older Americans living in nursing ...
Commentary

COVID-19 has shown us how dysfunctional the American regulatory state can be

In November, the Food and Drug Administration approved the first rapid at-home coronavirus test. That would seem to be unabashedly good news. But it’s actually an indictment of federal regulators, who have moved at a snail’s pace in the fight against the coronavirus. These delays have been concerning for folks ...
Commentary

Reforming Rebate Contracting will Improve Drug Affordability

By Wayne Winegarden and Robert Popovian The Department of Health and Human Services (HHS) finalized a regulation on November 20, 2020 that removed the safe harbor protections for rebates on prescription drugs paid to pharmacy benefit managers (PBMs) and Part D plans. This analysis evaluates the expected impact from this ...
Commentary

Work Requirements Can Preserve Medicaid For Those Who Need It Most

This month, the U.S. Supreme Court agreed to hear a case early next year that will decide whether states have the power to impose work requirements as a condition of receiving Medicaid benefits. The question before the high court is a legal one. But as a matter of policy, work requirements are a great ...
Commentary

The coming vaccine doesn’t mean we should delay routine care

This week, the first round of people began receiving a vaccine against COVID-19 in the United States. That offers some hope that we’ll finally be able to get the pandemic under control. Some people may take the arrival of a vaccine to mean that they can wait a few more months for ...
Commentary

Moderna COVID vaccine gets key endorsement — vaccinations are safe and will end pandemic

The vote Thursday by a U.S. Food and Drug Administration advisory panel to recommend an emergency use authorization for Moderna’s coronavirus vaccine is an important and welcome step in our battle to end the COVID-19 pandemic. Vaccinations are now underway with the Pfizer-BioNTech vaccine. People will begin received inoculations of the ...
Drug Pricing

NEW BRIEF: Tearing Down Drug ‘Rebate Walls’ Would Save Patients, Improve Health Care Outcomes

Tearing down drug “rebate walls” that increase patient costs and block access to cheaper and often more effective medications would increase competition, lower out-of-pocket costs, and improve health outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click ...
Scroll to Top